Literature DB >> 27887780

Insight and white matter fractional anisotropy in first-episode schizophrenia.

Laila Asmal1, Stefan du Plessis2, Matthijs Vink3, Jean-Paul Fouche4, Bonginkosi Chiliza2, Robin Emsley2.   

Abstract

Impaired insight is a hallmark feature of schizophrenia. Structural studies implicate predominantly prefrontal, cingulate, cuneus/precuneus, and inferior temporal brain regions. The cortical midline structures (CMS) are also implicated in functional studies primarily through self-reflective processing tasks. However, few studies have explored the relationship between white matter tracts and insight in schizophrenia, and none in first-episode schizophrenia (FES). Here, we examined for fractional anisotropy (FA) differences in 89 minimally treated FES patients and 98 matched controls, and identified those FA differences associated with impaired clinical insight in patients. We found widespread FA reduction in FES patients compared to controls. Poorer insight in patients was predicted by lower FA values in a number of white matter tracts with a predilection for tracts associated with cortical midline structures (fronto-occipital, cingulate, cingulate hippocampus, uncinate, anterior corona radiata), and more severe depressive symptoms. The association between FA abnormalities and insight was most robust for the awareness of symptoms and illness awareness domains. Our study implicates a network of tracts involved in impaired insight in schizophrenia with a predilection for the CMS. This study is a first step in delineating the white matter tracts involved in insight impairment in schizophrenia prior to chronicity.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2016        PMID: 27887780     DOI: 10.1016/j.schres.2016.11.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  9 in total

1.  Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia.

Authors:  Long-Biao Cui; Yongbin Wei; Yi-Bin Xi; Alessandra Griffa; Siemon C De Lange; René S Kahn; Hong Yin; Martijn P Van den Heuvel
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

2.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments.

Authors:  Paul H Lysaker; Michelle L Pattison; Bethany L Leonhardt; Scott Phelps; Jenifer L Vohs
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

3.  Childhood Trauma Associated White Matter Abnormalities in First-Episode Schizophrenia.

Authors:  Laila Asmal; Sanja Kilian; Stefan du Plessis; Frederika Scheffler; Bonginkosi Chiliza; Jean-Paul Fouche; Soraya Seedat; Paola Dazzan; Robin Emsley
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

4.  Promoting insight and recovery in the context of the "insight paradox".

Authors:  Lawrence H Yang; Shana S Samuel; Charisse Tay; Young Cho
Journal:  Schizophr Res       Date:  2020-05-24       Impact factor: 4.662

5.  Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrity.

Authors:  Philip Gerretsen; Tarek K Rajji; Parita Shah; Saba Shahab; Marcos Sanches; Ariel Graff-Guerrero; Mahesh Menon; Bruce G Pollock; David C Mamo; Benoit H Mulsant; Aristotle N Voineskos
Journal:  NPJ Schizophr       Date:  2019-04-29

6.  Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia.

Authors:  Mi Yang; Shan Gao; Xiangyang Zhang
Journal:  Transl Psychiatry       Date:  2020-11-02       Impact factor: 6.222

7.  Differential power of placebo across major psychiatric disorders: a preliminary meta-analysis and machine learning study.

Authors:  Bo Cao; Yang S Liu; Alessandro Selvitella; Diego Librenza-Garcia; Ives Cavalcante Passos; Jeffrey Sawalha; Pedro Ballester; Jianshan Chen; Shimiao Dong; Fei Wang; Flavio Kapczinski; Serdar M Dursun; Xin-Min Li; Russell Greiner; Andrew Greenshaw
Journal:  Sci Rep       Date:  2021-10-29       Impact factor: 4.379

8.  Meta-analysis of structural and functional brain abnormalities in schizophrenia with persistent negative symptoms using activation likelihood estimation.

Authors:  Tingting Zhu; Zixu Wang; Chao Zhou; Xinyu Fang; Chengbing Huang; Chunming Xie; Honglin Ge; Zheng Yan; Xiangrong Zhang; Jiu Chen
Journal:  Front Psychiatry       Date:  2022-09-27       Impact factor: 5.435

9.  The Effects of Bi-Anodal tDCS Over the Prefrontal Cortex Regions With Extracephalic Reference Placement on Insight Levels and Cardio-Respiratory and Autonomic Functions in Schizophrenia Patients and Exploratory Biomarker Analyses for Treatment Response.

Authors:  Chuan-Chia Chang; Yu-Chen Kao; Che-Yi Chao; Nian-Sheng Tzeng; Hsin-An Chang
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.